Laser-assisted spatiotemporal control of Noxa expression in engineering bacteria for treating tumors.
- Author:
Tingfang GAN
1
;
Naiming ZHENG
1
;
Huifeng LI
1
;
Jinrui XU
1
;
Ningning WU
1
;
Lixin MA
1
;
Yunhong HU
1
Author Information
- Publication Type:Journal Article
- Keywords: Noxa; antitumor; bacterial therapy; engineering bacteria; photothermal therapy
- MeSH: Escherichia coli/radiation effects*; Animals; Humans; Lasers; Mice; Proto-Oncogene Proteins c-bcl-2/biosynthesis*; Neoplasms/therapy*; Genetic Engineering; Cell Line, Tumor; Escherichia coli Proteins/genetics*
- From: Chinese Journal of Biotechnology 2025;41(8):3199-3213
- CountryChina
- Language:Chinese
- Abstract: Bacterial therapy has attracted increasing attention due to its special mechanism and abundant applications. With the flourishing development of synthetic biology, therapeutic genes have been introduced into engineering bacteria to improve their antitumor efficacy. However, it is difficult to spatiotemporally control the expression of these therapeutic genes at the tumor site in vivo, thereby considerably limiting the application of engineered bacteria in tumor treatment. To resolve this problem, we constructed a temperature-responsive bacterial strain capable of triggering the expression of exogenous genes in a laser-controllable way. Noxa, a pro-apoptotic protein, is chosen to test the expression of exogenous protein and its anti-tumor effect in engineered bacteria upon laser irradiation. Firstly, Noxa was fused to the C-terminus of the bacterial outer membrane protein cytolysin A (ClyA), and then the recombinant gene fragment ClyA-Noxa was inserted into the temperature-sensitive plasmid pBV220 and the recombinant plasmid was transformed into non-pathogenic Escherichia coli MG1655. Thus, we constructed the engineering strain (TRB@Noxa) that could express Noxa on the bacterial surface. TRB@Noxa could target and colonize the tumor tissue without causing notable host toxicity. The bacterial infection triggered thrombosis in the tumor tissue, resulting in the darkness of tumor sites. In a xenograft mouse tumor model, our strategy demonstrated precise tumor targeting and strong tumor inhibition. In conclusion, we successfully constructed a new engineering bacterial strain TRB@Noxa. TRB@Noxa combined with photothermal therapy could arrest tumor growth in the absence of photosensitizers, which represents an appealing method for antitumor therapy in the future.
